4D Molecular Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 4.56 M | $14.74 M | 0.00% | 8.19% |
| BVF INC/IL | 05/15/2025 | 4.56 M | $14.73 M | 70.79% | 8.18% |
| BLACKROCK, INC. | 05/02/2025 | 4.55 M | $14.69 M | -7.60% | 8.16% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 4.17 M | $13.46 M | -2.49% | 7.48% |
| VANGUARD GROUP INC | 05/09/2025 | 2.76 M | $8.91 M | -3.60% | 4.95% |
| NOVO HOLDINGS A/S | 05/15/2025 | 1.95 M | $6.30 M | 30.00% | 3.50% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 1.89 M | $6.87 M | -16.00% | 3.39% |
| MORGAN STANLEY | 05/15/2025 | 1.78 M | $5.74 M | -4.63% | 3.19% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 1.63 M | $5.28 M | 15.01% | 2.93% |
| FEDERATED HERMES, INC. | 05/08/2025 | 1.25 M | $4.04 M | 33,131.82% | 2.24% |
| STATE STREET CORP | 05/15/2025 | 1.03 M | $3.32 M | -7.62% | 1.84% |
| REDMILE GROUP, LLC | 05/15/2025 | 997.24 K | $3.22 M | -16.68% | 1.79% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 963.27 K | $3.11 M | -4.83% | 1.73% |
| JPMORGAN CHASE & CO | 05/12/2025 | 886.71 K | $2.86 M | 8.13% | 1.59% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 698.31 K | $2.26 M | 81.44% | 1.25% |
| VR ADVISER, LLC | 05/15/2025 | 677.60 K | $2.19 M | -77.05% | 1.22% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 650.96 K | $2.10 M | -0.39% | 1.17% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 527.27 K | $1.70 M | -33.64% | 0.95% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 490.40 K | $1.58 M | 287.97% | 0.88% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 461.46 K | $1.49 M | 46.96% | 0.83% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 05/14/2025 | 412.00 K | $1.33 M | -10.24% | 0.74% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 400.61 K | $1.29 M | 1,103.42% | 0.72% |
| NORTHERN TRUST CORP | 05/13/2025 | 380.92 K | $1.23 M | -13.56% | 0.68% |
| DECHENG CAPITAL LLC | 05/08/2025 | 335.52 K | $1.08 M | -16.12% | 0.60% |
| CITADEL ADVISORS LLC | 05/15/2025 | 331.21 K | $1.07 M | -45.26% | 0.59% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 300.00 K | $969.00 K | 0.00% | 0.54% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 294.38 K | $950.84 K | 160.73% | 0.53% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 282.78 K | $913.38 K | -8.37% | 0.51% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 247.47 K | $799.33 K | 39.59% | 0.44% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 236.16 K | $762.79 K | -2.36% | 0.42% |
| 04/30/2025 | 195.85 K | $632.61 K | 35.31% | 0.35% | |
| MARSHALL WACE, LLP | 05/15/2025 | 158.29 K | $511.27 K | 200.11% | 0.28% |
| 05/12/2025 | 150.31 K | $485.52 K | 100.00% | 0.27% | |
| PERIGON WEALTH MANAGEMENT, LLC | 04/23/2025 | 146.13 K | $472.01 K | 0.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 134.85 K | $435.56 K | -7.60% | 0.24% |
| PRIVIUM FUND MANAGEMENT B.V. | 05/09/2025 | 131.00 K | $423.13 K | 8.26% | 0.24% |
| INVESCO LTD. | 05/12/2025 | 117.77 K | $380.39 K | 318.25% | 0.21% |
| BARCLAYS PLC | 05/15/2025 | 97.04 K | $312.00 K | -7.79% | 0.17% |
| CITIGROUP INC | 05/12/2025 | 85.08 K | $274.81 K | -9.12% | 0.15% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 84.18 K | $271.89 K | -54.23% | 0.15% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 84.17 K | $271.88 K | -81.25% | 0.15% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 74.57 K | $241.50 K | -43.50% | 0.13% |
| ENGINEERS GATE MANAGER LP | 05/15/2025 | 73.42 K | $237.15 K | -57.17% | 0.13% |
| RHUMBLINE ADVISERS | 04/08/2025 | 70.80 K | $228.68 K | -3.58% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 70.72 K | $228.43 K | 116.08% | 0.13% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 55.87 K | $180.46 K | 0.00% | 0.10% |
| PDT PARTNERS, LLC | 05/15/2025 | 55.00 K | $177.65 K | -9.71% | 0.10% |
| HSBC HOLDINGS PLC | 05/14/2025 | 52.17 K | $166.43 K | 51.60% | 0.09% |
| MAN GROUP PLC | 05/15/2025 | 51.95 K | $167.81 K | 100.00% | 0.09% |
| HRT FINANCIAL LP | 05/15/2025 | 50.40 K | $162.00 K | -39.58% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 160 institutional investors and hedge funds held shares of 4D Molecular Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 4.56 M
BVF INC/IL: 4.56 M
BlackRock, Inc.: 4.55 M
GOLDMAN SACHS GROUP INC: 4.17 M
VANGUARD GROUP INC: 2.76 M
Novo Holdings A/S: 1.95 M
77.30% of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 47.92 M shares in the last 24 months. This purchase volume represents approximately $167.26 M in transactions.